Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.
Kim GM, Jeung HC, Rha SY, Kim HS, Jung I, Nam BH, Lee KH, Chung HC.
Eur J Cancer. 2012 Mar;48(4):518-26. Epub 2012 Jan 12.
Related citations
MicroRNA-610 inhibits the migration and invasion of gastric cancer cells by suppressing the expression of vasodilator-stimulated phosphoprotein.
Wang J, Zhang J, Wu J, Luo D, Su K, Shi W, Liu J, Tian Y, Wei L.
Eur J Cancer. 2011 Dec 19. [Epub ahead of print]
Venous thromboembolism (VTE) in patients with advanced gastric cancer: an Asian experience.
Kang MJ, Ryoo BY, Ryu MH, Koo DH, Chang HM, Lee JL, Kim TW, Kang YK.
Eur J Cancer. 2012 Mar;48(4):492-500. Epub 2011 Dec 12.
Growth factor receptor-related therapy for gastric cancer.
Cervantes A.
Eur J Cancer. 2011 Sep;47 Suppl 3:S324-5. Review. No abstract available.
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Thuss-Patience PC, Kretzschmar A, Bichev D, Deist T, Hinke A, Breithaupt K, Dogan Y, Gebauer B, Schumacher G, Reichardt P.
Eur J Cancer. 2011 Oct;47(15):2306-14.
Motor vehicle exposure and risk of oesophageal adenocarcinoma.
Lagergren J, Jansson C, Lu Y.
Eur J Cancer. 2011 Jul;47(10):1446-9. Epub 2011 May 12.
miR-429 modulates the expression of c-myc in human gastric carcinoma cells.
Sun T, Wang C, Xing J, Wu D.
Eur J Cancer. 2011 Nov;47(17):2552-9. Epub 2011 Jun 16.
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer.
Moehler M, Mueller A, Hartmann JT, Ebert MP, Al-Batran SE, Reimer P, Weihrauch M, Lordick F, Trarbach T, Biesterfeld S, Kabisch M, Wachtlin D, Galle PR; German Arbeitsgemeinschaft Internistische Onkologie (AIO).
Eur J Cancer. 2011 Jul;47(10):1511-20. Epub 2011 May 9.
Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer.
Hawkes E, Okines AF, Papamichael D, Rao S, Ashley S, Charalambous H, Koukouma A, Chau I, Cunningham D.
Eur J Cancer. 2011 May;47(8):1146-51. Epub 2011 Jan 25.
Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in Sweden.
Ljung R, Martin L, Lagergren J.
Eur J Cancer. 2011 Sep;47(14):2128-32. Epub 2011 Apr 12.
DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer.
Mutze K, Langer R, Schumacher F, Becker K, Ott K, Novotny A, Hapfelmeier A, Höfler H, Keller G.
Eur J Cancer. 2011 Aug;47(12):1817-25. Epub 2011 Mar 31.
The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer.
den Hoed CM, van Eijck BC, Capelle LG, van Dekken H, Biermann K, Siersema PD, Kuipers EJ.
Eur J Cancer. 2011 May;47(8):1211-8. Epub 2011 Jan 14.
WITHDRAWN: Oral disease and risk of esophageal and gastric cancer in a nationwide nested case-control study in Sweden.
Eur J Cancer. 2010 Dec 28. [Epub ahead of print]
A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis.
Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, Huang D, Chen X, Zhang H, Zhuang R, Deng T, Liu H, Yin J, Wang S, Zen K, Ba Y, Zhang CY.
Eur J Cancer. 2011 Mar;47(5):784-91. Epub 2010 Nov 26.
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer.
Corso G, Pedrazzani C, Pinheiro H, Fernandes E, Marrelli D, Rinnovati A, Pascale V, Seruca R, Oliveira C, Roviello F.
Eur J Cancer. 2011 Mar;47(4):631-9. Epub 2010 Nov 22. Review.
Oncogenic mutations in gastric cancer with microsatellite instability.
Corso G, Velho S, Paredes J, Pedrazzani C, Martins D, Milanezi F, Pascale V, Vindigni C, Pinheiro H, Leite M, Marrelli D, Sousa S, Carneiro F, Oliveira C, Roviello F, Seruca R.
Eur J Cancer. 2011 Feb;47(3):443-51.
Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women.
Freedman ND, Derakhshan MH, Abnet CC, Schatzkin A, Hollenbeck AR, McColl KE.
Eur J Cancer. 2010 Sep;46(13):2473-8. Epub 2010 Jun 3.
The addition of pravastatin to chemotherapy in advanced gastric carcinoma: a randomised phase II trial.
Konings IR, van der Gaast A, van der Wijk LJ, de Jongh FE, Eskens FA, Sleijfer S.
Eur J Cancer. 2010 Dec;46(18):3200-4. Epub 2010 Aug 18.
MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion.
Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT, Xia YJ, Ye ZY, Tao HQ.
Eur J Cancer. 2010 Aug;46(12):2295-303.
Trastuzumab in gastric cancer.
Okines AF, Cunningham D.
Eur J Cancer. 2010 Jul;46(11):1949-59. Epub 2010 Jun 11.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on